For instance, compounds such as mdivi-1, P110, dynasore, and S3, which interfere with Drp1 function or inhibit MFN1/2, effectively reduce excessive mitochondrial fission, highlighting their potential therapeutic value in treating metabolic disorders [94]. Here, DNM1L is linked to metabolic disease.